Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P553 | DOI: 10.1530/endoabs.110.P553

ECEESPE2025 Poster Presentations Fetal and Neonatal Endocrinology (15 abstracts)

MEN2B syndrome, the impossible clinical challenge and how genomic newborn screening will improve morbidity and mortality

Tashunka Taylor-Miller1, Katherine Tucker2, 3, Ella Sugo4, Antoinette Anazodo3, 5 & David Mowat1, 3


1Centre for Clinical Genetics, Sydney Children’s Hospital Randwick, Sydney, Australia; 2Hereditary Cancer Centre, Prince of Wales Hospital Randwick, Sydney, Australia; 3Discipline of Paediatrics, School of Clinical Medicine, University of NSW Medicine & Health, Sydney, Australia; 4Department of Anatomical Histopathology, John Hunter Hospital, Newcastle, Australia; 5Kids Cancer Centre, Sydney Children’s Hospital, Randwick, Sydney, Australia.


JOINT1370

Background: MEN2B syndrome, due to pathogenic M918T variant in the RET proto-oncogene, carries very high morbidity and mortality with >20% of patients deceased by 25 years of age. Larger cohort studies have demonstrated that thyroidectomy performed <1 year of age drastically changes morbidity and likely mortality. However, identifying these children is clinically extremely difficult due to the constellation of non-specific gastrointestinal, musculoskeletal and endocrine symptoms, which results in the mean age of diagnosis ~13 years of age by which time medullary thyroid carcinoma has metastasised.

Aims: We advocate that including the M918T variant in RET gene in universal newborn screening programs and careful exclusion of intestinal ganglioneuromatosis on histopathology is the only way to enable earlier identification of affected children, which will improve clinical outcomes and provide an opportunity for thyroidectomy within the first year of life.

Results: We present a 5-patient case series with excellent clinical photography and histopathology images, including subglottic mucosal ganglioneuromatosis which has not previously been described.

Conclusion: We highlight that there are unique clinical features identifiable in the first 12 months of life of severe, persistent chronic constipation and alacrima (tearless crying) but often their significance is not recognised. There are also identifiable histopathological features of intestinal ganglioneuromatosis on gastrointestinal biopsies with adequate submucosa when the reviewing pathologist maintains a broad differential diagnosis mindset and isn’t blinkered by only excluding Hirschsprung disease.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches